Achieve Life Sciences, Inc. (ACHV) Financial Statements (2024 and earlier)

Company Profile

Business Address 22722 29TH DR. SE
SEATTLE, WA 98021
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:24,771,00043,022,00035,853,00016,700,00014,600,0005,284,000
Cash and cash equivalents24,771,00043,022,00035,853,00016,664,0009,515,0005,284,000
Short-term investments     5,089,000 
Other undisclosed cash, cash equivalents, and short-term investments    36,000(4,000) 
Restricted cash and investments      222,000
Receivables105,000153,000 8,0007,0009,000
Prepaid expense    662,000926,000393,000
Other undisclosed current assets2,454,0001,419,0001,122,000(36,000)4,000 
Total current assets:27,330,00044,594,00036,975,00017,334,00015,537,0005,908,000
Noncurrent Assets
Operating lease, right-of-use asset123,00064,000146,000329,000
Property, plant and equipment 4,00015,00042,00057,00035,00059,000
Intangible assets, net (including goodwill)2,452,0002,675,0002,898,0003,121,0003,344,0003,566,000
Goodwill1,034,0001,034,0001,034,0001,034,0001,034,0001,034,000
Intangible assets, net (excluding goodwill)1,418,0001,641,0001,864,0002,087,0002,310,0002,532,000
Restricted cash and investments   50,00050,00050,00050,000
Other noncurrent assets   187,000187,000118,000309,000
Other undisclosed noncurrent assets62,000168,000    
Total noncurrent assets:2,641,0002,922,0003,323,0003,744,0003,547,0003,984,000
TOTAL ASSETS:29,971,00047,516,00040,298,00021,078,00019,084,0009,892,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,741,0003,129,0002,390,0002,279,0002,060,0001,109,000
Employee-related liabilities1,940,0001,474,0001,116,0001,168,000458,000
Accounts payable1,660,000841,000332,000859,000144,000213,000
Accrued liabilities2,081,000348,000584,000304,000748,000438,000
Debt 16,071,000  203,00011,00027,000
Other undisclosed current liabilities1,787,0001,421,000545,000387,0001,199,000877,000
Total current liabilities:21,599,0004,550,0002,935,0002,869,0003,270,0002,013,000
Noncurrent Liabilities
Long-term debt and lease obligation 14,924,00077,000159,00012,000 
Long-term debt, excluding current maturities 14,920,000    
Capital lease obligations12,000 
Liabilities, other than long-term debt69,000     
Operating lease, liability69,0004,00077,000159,000
Other undisclosed noncurrent liabilities  (4,000)(77,000)   
Total noncurrent liabilities:69,00014,924,00077,000159,00012,000 
Total liabilities:21,668,00019,474,0003,012,0003,028,0003,282,0002,013,000
Equity
Equity, attributable to parent8,303,00028,042,00037,286,00018,050,00015,802,0007,879,000
Common stock87,00079,00076,00041,00018,00012,000
Additional paid in capital144,148,000121,545,00097,640,00063,709,00041,161,00020,556,000
Accumulated other comprehensive income4,0004,0004,0004,0004,0005,000
Accumulated deficit(135,936,000)(93,586,000)(60,434,000)(45,704,000)(25,381,000)(12,694,000)
Total equity:8,303,00028,042,00037,286,00018,050,00015,802,0007,879,000
TOTAL LIABILITIES AND EQUITY:29,971,00047,516,00040,298,00021,078,00019,084,0009,892,000

Income Statement (P&L) (USD)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Operating expenses(41,036,000)(33,294,000)(14,950,000)(16,528,000)(12,813,000)(6,632,000)
Operating loss:(41,036,000)(33,294,000)(14,950,000)(16,528,000)(12,813,000)(6,632,000)
Nonoperating income (expense)(1,550,000)(58,000)20,000133,000126,000(7,002,000)
Investment income, nonoperating199,00017,00069,000170,000171,0001,293,000
Other nonoperating income (expense)40,000(75,000)(49,000)(37,000)(45,000)(35,000)
Interest and debt expense(1,789,000)     
Loss from continuing operations before equity method investments, income taxes:(44,375,000)(33,352,000)(14,930,000)(16,395,000)(12,687,000)(13,634,000)
Other undisclosed income from continuing operations before income taxes2,025,000200,000    
Loss from continuing operations before income taxes:(42,350,000)(33,152,000)(14,930,000)(16,395,000)(12,687,000)(13,634,000)
Income tax benefit      3,051,000
Loss from continuing operations:(42,350,000)(33,152,000)(14,930,000)(16,395,000)(12,687,000)(10,583,000)
Loss before gain (loss) on sale of properties:(33,152,000)(14,930,000)(16,395,000)(12,687,000)(10,583,000)
Other undisclosed net income (loss)  200,000   
Net loss:(42,350,000)(33,152,000)(14,730,000)(16,395,000)(12,687,000)(10,583,000)
Other undisclosed net income attributable to parent      
Net loss available to common stockholders, diluted:(42,350,000)(33,152,000)(14,730,000)(16,395,000)(12,687,000)(10,583,000)

Comprehensive Income (USD)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(42,350,000)(33,152,000)(14,730,000)(16,395,000)(12,687,000)(10,583,000)
Other comprehensive loss     (1,000) 
Comprehensive loss:(42,350,000)(33,152,000)(14,730,000)(16,395,000)(12,688,000)(10,583,000)
Other undisclosed comprehensive income, net of tax, attributable to parent     1,000 
Comprehensive loss, net of tax, attributable to parent:(42,350,000)(33,152,000)(14,730,000)(16,395,000)(12,687,000)(10,583,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: